Similar Papers

Paper Title
Journal
Date
Author
New insights into antiangiogenic therapy resistance in cancer: Mechanisms and therapeutic aspects.
Maohua Huang ... Minfeng Chen
Drug Resistance Updates | VOL. 64
Maohua Huang, et. al.Maohua Huang ... Minfeng Chen
01 Sep 2022
ENO2-derived phosphoenolpyruvate functions as an endogenous inhibitor of HDAC1 and confers resistance to antiangiogenic therapy.
Chenran Wang ...
Nature Metabolism | VOL. 5
Chenran Wang, et. al.Chenran Wang ...
04 Sep 2023
Issues regarding improving the impact of antiangiogenic drugs for the treatment of breast cancer
Robert S Kerbel
The Breast | VOL. 18
Robert S KerbelRobert S Kerbel
01 Oct 2009
Combination of Immunotherapy and Antiangiogenic Therapy in Cancer-a Rational Approach.
Sukhmani K Padda ... Karen L Reckamp
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | VOL. 16
Sukhmani K Padda, et. al.Sukhmani K Padda ... Karen L Reckamp
01 Feb 2021
View more papers

More From: Journal of the National Cancer Institute

Paper Title
Journal
Date
Author
Limiting surveillance in individuals with the Palestinian TP53 p. R181C founder variant-is it too soon to draw conclusions?
Meis Omran ... David Malkin
Journal of the National Cancer Institute | VOL. -
Meis Omran, et. al.Meis Omran ... David Malkin
06 Feb 2025
Impact of screening for HPV-positive oropharyngeal cancers: a microsimulation-based modeling study.
Rebecca Landy ... Anil K Chaturvedi
Journal of the National Cancer Institute | VOL. -
Rebecca Landy, et. al.Rebecca Landy ... Anil K Chaturvedi
06 Feb 2025
RE: Long-term survival across breslow thickness categories: Findings from a population-based study of 210 042 Australian melanoma patients.
Fangzheng Han ... Huaimin Liu
Journal of the National Cancer Institute | VOL. -
Fangzheng Han, et. al.Fangzheng Han ... Huaimin Liu
06 Feb 2025
Response to han and liu.
Serigne N Lo ... John F Thompson
Journal of the National Cancer Institute | VOL. -
Serigne N Lo, et. al.Serigne N Lo ... John F Thompson
06 Feb 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.